Logo image of CTS

CTS CORP (CTS) Stock Fundamental Analysis

NYSE:CTS - New York Stock Exchange, Inc. - US1265011056 - Common Stock - Currency: USD

43.3  +1.13 (+2.68%)

After market: 43.3 0 (0%)

Fundamental Rating

7

CTS gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 125 industry peers in the Electronic Equipment, Instruments & Components industry. CTS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CTS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year CTS was profitable.
In the past year CTS had a positive cash flow from operations.
Of the past 5 years CTS 4 years were profitable.
CTS had a positive operating cash flow in each of the past 5 years.
CTS Yearly Net Income VS EBIT VS OCF VS FCFCTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

With an excellent Return On Assets value of 7.89%, CTS belongs to the best of the industry, outperforming 89.60% of the companies in the same industry.
CTS has a better Return On Equity (11.21%) than 79.20% of its industry peers.
CTS has a Return On Invested Capital of 9.56%. This is amongst the best in the industry. CTS outperforms 82.40% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CTS is in line with the industry average of 9.38%.
Industry RankSector Rank
ROA 7.89%
ROE 11.21%
ROIC 9.56%
ROA(3y)7.9%
ROA(5y)4.59%
ROE(3y)11.4%
ROE(5y)6.67%
ROIC(3y)10.61%
ROIC(5y)10.13%
CTS Yearly ROA, ROE, ROICCTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

The Profit Margin of CTS (11.70%) is better than 88.00% of its industry peers.
In the last couple of years the Profit Margin of CTS has grown nicely.
The Operating Margin of CTS (15.39%) is better than 90.40% of its industry peers.
CTS's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 37.22%, CTS is in the better half of the industry, outperforming 64.00% of the companies in the same industry.
CTS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.39%
PM (TTM) 11.7%
GM 37.22%
OM growth 3Y-0.48%
OM growth 5Y2.89%
PM growth 3YN/A
PM growth 5Y7.92%
GM growth 3Y0.63%
GM growth 5Y1.76%
CTS Yearly Profit, Operating, Gross MarginsCTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CTS is still creating some value.
CTS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CTS has less shares outstanding
Compared to 1 year ago, CTS has a worse debt to assets ratio.
CTS Yearly Shares OutstandingCTS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CTS Yearly Total Debt VS Total AssetsCTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

CTS has an Altman-Z score of 5.88. This indicates that CTS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CTS (5.88) is better than 79.20% of its industry peers.
The Debt to FCF ratio of CTS is 1.12, which is an excellent value as it means it would take CTS, only 1.12 years of fcf income to pay off all of its debts.
CTS has a better Debt to FCF ratio (1.12) than 82.40% of its industry peers.
CTS has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.16, CTS is in line with its industry, outperforming 48.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.12
Altman-Z 5.88
ROIC/WACC1.1
WACC8.71%
CTS Yearly LT Debt VS Equity VS FCFCTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 2.63 indicates that CTS has no problem at all paying its short term obligations.
CTS has a Current ratio (2.63) which is in line with its industry peers.
A Quick Ratio of 2.05 indicates that CTS has no problem at all paying its short term obligations.
CTS has a better Quick ratio (2.05) than 61.60% of its industry peers.
Industry RankSector Rank
Current Ratio 2.63
Quick Ratio 2.05
CTS Yearly Current Assets VS Current LiabilitesCTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

CTS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.38%.
CTS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.40% yearly.
Looking at the last year, CTS shows a decrease in Revenue. The Revenue has decreased by -2.71% in the last year.
Measured over the past years, CTS shows a small growth in Revenue. The Revenue has been growing by 1.92% on average per year.
EPS 1Y (TTM)3.38%
EPS 3Y3.98%
EPS 5Y8.4%
EPS Q2Q%-6.38%
Revenue 1Y (TTM)-2.71%
Revenue growth 3Y0.18%
Revenue growth 5Y1.92%
Sales Q2Q%0.02%

3.2 Future

Based on estimates for the next years, CTS will show a small growth in Earnings Per Share. The EPS will grow by 5.91% on average per year.
Based on estimates for the next years, CTS will show a small growth in Revenue. The Revenue will grow by 4.63% on average per year.
EPS Next Y2.4%
EPS Next 2Y5.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.32%
Revenue Next 2Y4.63%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CTS Yearly Revenue VS EstimatesCTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
CTS Yearly EPS VS EstimatesCTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 20.23, the valuation of CTS can be described as rather expensive.
Based on the Price/Earnings ratio, CTS is valued a bit cheaper than 75.20% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.91, CTS is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 17.79, the valuation of CTS can be described as rather expensive.
Based on the Price/Forward Earnings ratio, CTS is valued a bit cheaper than the industry average as 71.20% of the companies are valued more expensively.
CTS's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.46.
Industry RankSector Rank
PE 20.23
Fwd PE 17.79
CTS Price Earnings VS Forward Price EarningsCTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CTS is valued a bit cheaper than the industry average as 76.80% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CTS is valued cheaply inside the industry as 85.60% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 16.69
EV/EBITDA 11.56
CTS Per share dataCTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of CTS may justify a higher PE ratio.
PEG (NY)8.44
PEG (5Y)2.41
EPS Next 2Y5.91%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

CTS has a yearly dividend return of 0.39%, which is pretty low.
Compared to an average industry Dividend Yield of 2.02, CTS pays a better dividend. On top of this CTS pays more dividend than 82.40% of the companies listed in the same industry.
With a Dividend Yield of 0.39, CTS pays less dividend than the S&P500 average, which is at 2.43.
Industry RankSector Rank
Dividend Yield 0.39%

5.2 History

The dividend of CTS has a limited annual growth rate of 0.16%.
CTS has paid a dividend for at least 10 years, which is a reliable track record.
CTS has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.16%
Div Incr Years0
Div Non Decr Years31
CTS Yearly Dividends per shareCTS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

8.04% of the earnings are spent on dividend by CTS. This is a low number and sustainable payout ratio.
CTS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP8.04%
EPS Next 2Y5.91%
EPS Next 3YN/A
CTS Yearly Income VS Free CF VS DividendCTS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M
CTS Dividend Payout.CTS Dividend Payout, showing the Payout Ratio.CTS Dividend Payout.PayoutRetained Earnings

CTS CORP

NYSE:CTS (6/24/2025, 8:27:55 PM)

After market: 43.3 0 (0%)

43.3

+1.13 (+2.68%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-28 2025-07-28/bmo
Inst Owners97.73%
Inst Owner Change-0.86%
Ins Owners2.13%
Ins Owner Change4.48%
Market Cap1.29B
Analysts45
Price Target43.86 (1.29%)
Short Float %1.59%
Short Ratio2.47
Dividend
Industry RankSector Rank
Dividend Yield 0.39%
Yearly Dividend0.16
Dividend Growth(5Y)0.16%
DP8.04%
Div Incr Years0
Div Non Decr Years31
Ex-Date06-27 2025-06-27 (0.04)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.96%
Min EPS beat(2)-11.09%
Max EPS beat(2)-2.82%
EPS beat(4)2
Avg EPS beat(4)0.76%
Min EPS beat(4)-11.09%
Max EPS beat(4)15.51%
EPS beat(8)5
Avg EPS beat(8)2.28%
EPS beat(12)7
Avg EPS beat(12)1.36%
EPS beat(16)11
Avg EPS beat(16)5.97%
Revenue beat(2)0
Avg Revenue beat(2)-4.13%
Min Revenue beat(2)-4.99%
Max Revenue beat(2)-3.26%
Revenue beat(4)0
Avg Revenue beat(4)-3.16%
Min Revenue beat(4)-4.99%
Max Revenue beat(4)-1.03%
Revenue beat(8)0
Avg Revenue beat(8)-2.89%
Revenue beat(12)3
Avg Revenue beat(12)-2.17%
Revenue beat(16)7
Avg Revenue beat(16)-0.15%
PT rev (1m)0%
PT rev (3m)-8.51%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.78%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.86%
Valuation
Industry RankSector Rank
PE 20.23
Fwd PE 17.79
P/S 2.51
P/FCF 16.69
P/OCF 13.39
P/B 2.4
P/tB 7.47
EV/EBITDA 11.56
EPS(TTM)2.14
EY4.94%
EPS(NY)2.43
Fwd EY5.62%
FCF(TTM)2.59
FCFY5.99%
OCF(TTM)3.23
OCFY7.47%
SpS17.29
BVpS18.04
TBVpS5.8
PEG (NY)8.44
PEG (5Y)2.41
Profitability
Industry RankSector Rank
ROA 7.89%
ROE 11.21%
ROCE 11.79%
ROIC 9.56%
ROICexc 11.04%
ROICexgc 29.58%
OM 15.39%
PM (TTM) 11.7%
GM 37.22%
FCFM 15.01%
ROA(3y)7.9%
ROA(5y)4.59%
ROE(3y)11.4%
ROE(5y)6.67%
ROIC(3y)10.61%
ROIC(5y)10.13%
ROICexc(3y)13.62%
ROICexc(5y)13.04%
ROICexgc(3y)31.83%
ROICexgc(5y)27.79%
ROCE(3y)13.09%
ROCE(5y)12.49%
ROICexcg growth 3Y2.59%
ROICexcg growth 5Y8.96%
ROICexc growth 3Y-10.96%
ROICexc growth 5Y-0.3%
OM growth 3Y-0.48%
OM growth 5Y2.89%
PM growth 3YN/A
PM growth 5Y7.92%
GM growth 3Y0.63%
GM growth 5Y1.76%
F-Score6
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.12
Debt/EBITDA 0.78
Cap/Depr 59.44%
Cap/Sales 3.7%
Interest Coverage 17.44
Cash Conversion 86.57%
Profit Quality 128.26%
Current Ratio 2.63
Quick Ratio 2.05
Altman-Z 5.88
F-Score6
WACC8.71%
ROIC/WACC1.1
Cap/Depr(3y)53.27%
Cap/Depr(5y)54.74%
Cap/Sales(3y)2.91%
Cap/Sales(5y)3.06%
Profit Quality(3y)146.84%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.38%
EPS 3Y3.98%
EPS 5Y8.4%
EPS Q2Q%-6.38%
EPS Next Y2.4%
EPS Next 2Y5.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.71%
Revenue growth 3Y0.18%
Revenue growth 5Y1.92%
Sales Q2Q%0.02%
Revenue Next Year2.32%
Revenue Next 2Y4.63%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.46%
EBIT growth 3Y-0.29%
EBIT growth 5Y4.86%
EBIT Next Year26.49%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-20.69%
FCF growth 3Y4.58%
FCF growth 5Y13.56%
OCF growth 1Y-14.68%
OCF growth 3Y4.85%
OCF growth 5Y9.04%